Fortune Journals

Fortune Journal of Health Sciences

ISSN: 2644-2906 Peer Reviewed Open Access
Submit Manuscript →

Mycologic Epidemiology and Antifungal Susceptibility Patterns of Otomycosis in Yaounde, Cameroon: A Cross Sectional Study Revealing Candida albicans Dorminance and Nystatin Sensitivity

Vol 7, Issue 1 Pages 37–43 Published: 03 Feb 2024
Stanley Nkemnji Awungafac*, 1, Laure Ngando Moudoute2, Elvis Tambe Akem3, Paul Nkemtendong Tolefac4, Alexis Ndjolo5
Article Information
Citation: Awungafac SN, Ngando ML, Akem, ET, Tolefac PN, & Ndjolo A. Mycologic epidemiology and antifungal susceptibility patterns of otomycosis in Yaounde, Cameroon: A cross-sectional study revealing Candida albicans dominance and nystatin sensitivity. Fortune Journal of Health Sciences. 7 (2024): 37-43.

DOI: 10.26502/fjhs.162

Share
Abstract
Introduction: Otomycosis, or fungal otitis externa, has typically been described as fungal infection of the external auditory canal, with infrequent complications involving the middle ear. With an estimated global prevalence of 10%, a wide range of pathogens are implicated, which could have a significant impact on treatment outcomes in immunosuppressive conditions and the concurrent use of topical antibiotics/steroid preparations. Considering the limited data on this disease in Cameroon and the impact of various factors, including significant population growth and change, climate variations, and an increase in the number of patients, the epidemiology of otomycosis may have undergone substantial alterations over the years. There is therefore a need to characterize the mycologic epidemiology and susceptibility patterns for better treatment outcomes.
Keywords

Otomycosis, Mycological profiles, Antifungal Susceptibility patterns

Article Details
1. Introduction
Article Views
1,848
Total Views
Download PDF
Article Details
  • Volume7
  • Issue1
  • Pages37–43
  • Published03 Feb 2024
  • ISSN2644-2906
  • DOI10.26502/fjhs.162
Journal

Fortune Journal of Health Sciences

Impact Factor: 6.2
Submit Manuscript
© 2016–2026, Copyrights Fortune Journals. All Rights Reserved.